TNF-α Deficiency Prevents Renal Inflammation and Oxidative Stress in Obese Mice

Kidney and Blood Pressure Research

Volumn 42, Issue 3, 2017, Pages 416-427

  Gai, Zhibo ^b   Kullak Ublick, Gerd A ^b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Apoptosis; Glomerulosclerosis; High fat diet; Inflammation; Obesity; Oxidative stress; Renal fibrosis; TNF

Indexed keywords

ALBUMIN; FATTY ACID; LIPID; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHOW DIET; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; IN VITRO STUDY; INFLAMMATION; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LIPID DIET; LIPID STORAGE; MOUSE; NEPHRITIS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; WILD TYPE MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; COMPLICATION; DEFICIENCY; DRUG EFFECT; INJURIES; KIDNEY;

ANIMALS; DIET, HIGH-FAT; KIDNEY; LIPIDS; MICE; NEPHRITIS; OBESITY; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85023744912     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000478869     Document Type: Article

References (42)

1. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH: The disease burden associated with overweight and obesity. JAMA 1999;282:1523-1529.
2. Xiong XQ, Chen WW, Zhu GQ: Adipose afferent reflex: sympathetic activation and obesity hypertension. Acta Physiol (Oxf) 2014;210:468-478.
3. Gai Z, Hiller C, Chin SH, Hofstetter L, Stieger B, Konrad D, Kullak-Ublick GA: Uninephrectomy augments the effects of high fat diet induced obesity on gene expression in mouse kidney. Biochim Biophys Acta 2014;1842:1870-1878.
4. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001;59:1498-1509.
5. de Vries AP, Ruggenenti P, Ruan XZ, Praga M, Cruzado JM, Bajema IM, D'Agati VD, Lamb HJ, Pongrac Barlovic D, Hojs R, Abbate M, Rodriquez R, Mogensen CE, Porrini E, Diabesity E-EWG: Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease. Lancet Diabetes Endocrinol 2014;2:417-426.
6. Cheng HY: Midlife body mass index and total mortality. JAMA 2006;295:1772; author reply 1772.
7. Frerichs LM, Araz OM, Huang TT: Modeling social transmission dynamics of unhealthy behaviors for evaluating prevention and treatment interventions on childhood obesity. PLoS One 2013;8:e82887.
8. Fernandez-Sanchez A, Madrigal-Santillan E, Bautista M, Esquivel-Soto J, Morales-Gonzalez A, Esquivel-Chirino C, Durante-Montiel I, Sanchez-Rivera G, Valadez-Vega C, Morales-Gonzalez JA: Inflammation, oxidative stress, and obesity. Int J Mol Sci 2011;12:3117-3132.
9. Tzanavari T, Giannogonas P, Karalis KP: TNF-alpha and obesity. Curr Dir Autoimmun 2010;11:145-156.
10. Savini I, Catani MV, Evangelista D, Gasperi V, Avigliano L: Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci 2013;14:10497-10538.
11. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-3670.
12. Agrawal NK, Kant S: Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes 2014;5:697-710.
13. Tong F, Luo L, Liu D: Effect of Intervention in Mast Cell Function Before Reperfusion on Renal Ischemia-Reperfusion Injury in Rats. Kidney Blood Press Res 2016;41:335-344.
14. Ramesh G, Reeves WB: Inflammatory cytokines in acute renal failure. Kidney Int Suppl 2004;10.1111/j.1523-1755.2004.09109.xS56-61.
15. He FF, Li HQ, Huang QX, Wang QY, Jiang HJ, Chen S, Su H, Zhang C, Wang YM: Tumor Necrosis Factor-Alpha and 8-Hydroxy-2'-Deoxyguanosine are Associated with Elevated Urinary Angiopoietin-2 Level in Type 2 Diabetic Patients with Albuminuria. Kidney Blood Press Res 2015;40:355-365.
16. Tran LT, MacLeod KM, McNeill JH: Chronic etanercept treatment prevents the development of hypertension in fructose-fed rats. Mol Cell Biochem 2009;330:219-228.
17. Therrien FJ, Agharazii M, Lebel M, Lariviere R: Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure. Am J Nephrol 2012;36:151-161.
18. Zhu X, Jiang S, Hu N, Luo F, Dong H, Kang YM, Jones KR, Zou Y, Xiong L, Ren J: Tumour necrosis factor-alpha inhibition with lenalidomide alleviates tissue oxidative injury and apoptosis in ob/ob obese mice. Clin Exp Pharmacol Physiol 2014;41:489-501.
19. Tsutamoto T, Wada A, Matsumoto T, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Yamamoto T, Horie H, Sugimoto Y, Kinoshita M: Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy. J Am Coll Cardiol 2001;37:2086-2092.
20. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, Namba M: Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 1998;98:794-799.
21. Suematsu N, Tsutsui H, Wen J, Kang D, Ikeuchi M, Ide T, Hayashidani S, Shiomi T, Kubota T, Hamasaki N, Takeshita A: Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003;107:1418-1423.
22. Mariappan N, Soorappan RN, Haque M, Sriramula S, Francis J: TNF-alpha-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol. Am J Physiol Heart Circ Physiol 2007;293:H2726-2737.
23. Caliskan Y, Ozluk Y, Celik D, Oztop N, Aksoy A, Ucar AS, Yazici H, Kilicaslan I, Sever MS: The Clinical Significance of Uric Acid and Complement Activation in the Progression of IgA Nephropathy. Kidney Blood Press Res 2016;41:148-157.
24. Gai Z, Zhou G, Gui T, Itoh S, Oikawa K, Uetani K, Muragaki Y: Trps1 haploinsufficiency promotes renal fibrosis by increasing Arkadia expression. J Am Soc Nephrol 2010;21:1468-1476.
25. Tan M, Li W, Zou G, Zhang C, Fang J: Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria. Kidney Blood Press Res 2015;40:200-206.
26. Pei H, Song X, Peng C, Tan Y, Li Y, Li X, Ma S, Wang Q, Huang R, Yang D, Li D, Gao E, Yang Y: TNF-alpha inhibitor protects against myocardial ischemia/reperfusion injury via Notch1-mediated suppression of oxidative/nitrative stress. Free Radic Biol Med 2015;82:114-121.
27. Gai Z, Chu L, Hiller C, Arsenijevic D, Penno CA, Montani JP, Odermatt A, Kullak-Ublick GA: Effect of chronic renal failure on the hepatic, intestinal, and renal expression of bile acid transporters. Am J Physiol Renal Physiol 2014;306:F130-137.
28. Bobulescu IA, Dubree M, Zhang J, McLeroy P, Moe OW: Effect of renal lipid accumulation on proximal tubule Na+/H+ exchange and ammonium secretion. Am J Physiol Renal Physiol 2008;294:F1315-1322.
29. Nanami M, Ookawara T, Otaki Y, Ito K, Moriguchi R, Miyagawa K, Hasuike Y, Izumi M, Eguchi H, Suzuki K, Nakanishi T: Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells. Arterioscler Thromb Vasc Biol 2005;25:2495-2501.
30. Wahba IM, Mak RH: Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007;2:550-562.
31. Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846.
32. Rodriguez-Hernandez H, Simental-Mendia LE, Rodriguez-Ramirez G, Reyes-Romero MA: Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013;2013:678159.
33. Endo M, Masaki T, Seike M, Yoshimatsu H: TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c). Exp Biol Med (Maywood) 2007;232:614-621.
34. Tanaka N, Matsubara T, Krausz KW, Patterson AD, Gonzalez FJ: Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology 2012;56:118-129.
35. Le Vee M, Lecureur V, Stieger B, Fardel O: Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 2009;37:685-693.
36. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE: Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice. Diabetes 1997;46:1526-1531.
37. Gai Z, Gui T, Hiller C, Kullak-Ublick GA: Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice. J Biol Chem 2016;291:2397-2411.
38. Sharma K: Obesity, oxidative stress, and fibrosis in chronic kidney disease. Kidney Int Suppl (2011) 2014;4:113-117.
39. Wang B, Trayhurn P: Acute and prolonged effects of TNF-alpha on the expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture. Pflugers Arch 2006;452:418-427.
40. Dandona P, Aljada A, Bandyopadhyay A: Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
41. Chatzigeorgiou A, Seijkens T, Zarzycka B, Engel D, Poggi M, van den Berg S, van den Berg S, Soehnlein O, Winkels H, Beckers L, Lievens D, Driessen A, Kusters P, Biessen E, Garcia-Martin R, Klotzsche-von Ameln A, Gijbels M, Noelle R, Boon L, Hackeng T, Schulte KM, Xu A, Vriend G, Nabuurs S, Chung KJ, Willems van Dijk K, Rensen PC, Gerdes N, de Winther M, Block NL, Schally AV, Weber C, Bornstein SR, Nicolaes G, Chavakis T, Lutgens E: Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. Proc Natl Acad Sci USA 2014;111:2686-2691.
42. Li L, Hua Y, Dong M, Li Q, Smith DT, Yuan M, Jones KR, Ren J: Short-term lenalidomide (Revlimid) administration ameliorates cardiomyocyte contractile dysfunction in ob/ob obese mice. Obesity (Silver Spring) 2012;20:2174-2185.